Periostin secreted from CAF promotes cancer progression and drug resistance in non-small cell lung cancer

被引：0
|
作者：
Suzawa, Ken [1 ]
Tomida, Shuta [2 ]
Shien, Kazuhiko
Yamamoto, Hiromasa [1 ]
Toyooka, Shinichi [3 ]
机构：
[1] Okayama Univ, Dept Thorac Breast & Endocrinol Surg, Grad Sch, Okayama, Japan
[2] Okayama Univ Hosp, Ctr Comprehens Genom Med, Okayama, Japan
[3] Okayama Univ, Grad Sch Med Dent Pharm Sci, Okayama, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1252
引用
收藏
页码：433 / 433
页数：1
相关论文
共 50 条
  • [21] Overexpression of KIAA0101 Promotes the Progression of Non-small Cell Lung Cancer
    Cao, He
    Zheng, Jing
    Yao, Yinan
    Yang, Qi
    Yan, Runlan
    Sun, Wenjia
    Ruan, Kexin
    Zhou, Jianya
    Zhou, Jianying
    JOURNAL OF CANCER, 2020, 11 (22): : 6663 - 6674
  • [22] Carboplatin/paclitaxelAcquired drug resistance and transformation of non-small cell lung cancer to small cell lung cancer: case report
    Reactions Weekly, 2020, 1804 (1) : 88 - 88
  • [23] Molecular mechanisms of non-small cell lung cancer growth and drug resistance
    Alam, S. K. Kayum
    Astone, Matteo
    Liu, Ping
    Wang, Li
    Coyle, Abbygail M.
    Dankert, Erin N.
    Hoffman, Dane K.
    Hall, Stephanie R.
    Zhang, Wei
    Kuang, Rui
    Roden, Anja C.
    Mansfield, Aaron S.
    Hoeppner, Luke H.
    CANCER RESEARCH, 2019, 79 (13)
  • [24] CrizotinibDevelopment of drug resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2018, 1733 (1) : 121 - 121
  • [25] Non-Small Cell Lung Cancer: Challenge and Improvement of Immune Drug Resistance
    Kong, Fanming
    Wang, Ziwei
    Liao, Dongying
    Zuo, Jinhui
    Xie, Hongxia
    Li, Xiaojiang
    Jia, Yingjie
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [26] Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?
    Iglesias, Venus Sosa
    Giuranno, Lorena
    Dubois, Ludwig J.
    Theys, Jan
    Vooijs, Marc
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [27] OsimertinibAcquired drug resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2018, 1721 (1) : 226 - 226
  • [28] Drug resistance to targeted therapeutic strategies in non-small cell lung cancer
    Liu, Wen-juan
    Du, Yue
    Wen, Ru
    Yang, Ming
    Xu, Jian
    PHARMACOLOGY & THERAPEUTICS, 2020, 206
  • [29] Overexpression of periostin predicts poor prognosis in non-small cell lung cancer
    Hong, Ling-Zhi
    Wei, Xiao-Wei
    Chen, Jin-Fei
    Shi, Yi
    ONCOLOGY LETTERS, 2013, 6 (06) : 1595 - 1603
  • [30] Periostin and tumor-stroma interactions in non-small cell lung cancer
    Nitsche, Ulrich
    Stangel, Daniela
    Pan, Zheng
    Schlitter, Anna Melissa
    Esposito, Irene
    Regel, Ivonne
    Raulefs, Susanne
    Friess, Helmut
    Kleeff, Joerg
    Erkan, Mert
    ONCOLOGY LETTERS, 2016, 12 (05) : 3804 - 3810
12345